cas: 937272-79-2 — see every product listed under this CAS number, including other names
(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 97% (CAS 937272-79-2) is a chemical reagent available from Chemat. Available pack sizes: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 250mg. Offered by: Chemat, BLDpharm.
| brand | Chemat |
|---|---|
| catalog number | Ch114A50-1mg |
| cas | 937272-79-2 |
| size | 1mg |
| availability | 5g |
Ask us about this product — we're happy to help.
| brand | size | price | |
|---|---|---|---|
| Chemat | 1mg | 160.40 Pln | |
| Chemat | 2mg | 213.20 Pln | |
| Chemat | 5mg | 357.20 Pln | |
| Chemat | 10mg | 568.40 Pln | |
| Chemat | 25mg | 890.00 Pln | |
| Chemat | 50mg | 1058.00 Pln | |
| Chemat | 100mg | 1254.80 Pln | |
| Chemat | 250mg | 2325.20 Pln | |
| Chemat | 1g | 6170.00 Pln | |
| BLDpharm | 1mg | 197.73 Pln | |
| BLDpharm | 10mg | 525.40 Pln | |
| BLDpharm | 100mg | 1541.70 Pln | |
| BLDpharm | 250mg | 2857.91 Pln | |
| BLDpharm | 1g | 7595.13 Pln |
| purity | 97% |
|---|---|
| delivery time | 3 weeks |
Pacritinib is an azamacrocycle with formula C28H32N4O3. It is a Janus kinase inhibitor and its citrate salt is approved for the treatment of intermediate or high risk, primary or secondary myelofibrosis. It has a role as an antineoplastic agent, an anti-inflammatory agent, an apoptosis inducer and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It is a member of benzenes, a cyclic ether, a member of pyrrolidines and an azamacrocycle. It is a conjugate base of a pacritinib(1+).
Source: ChEBI
| Molecular formula | C28H32N4O3 |
|---|---|
| Molecular weight | 472.6 g/mol |
| IUPAC name | (16E)-11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8(26),9,11,16,21(25),22-decaene |
| InChIKey | HWXVIOGONBBTBY-ONEGZZNKSA-N |
| SMILES | C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2 |
Computed by PubChem (NCBI)